노화를 방지하는 미량원소 물질 - 비타민 C, E, 코엔자임큐텐, alpha-lipoic acid, 크롬, L-Carnitine, quercetin

[문형철]

beyond reason

미량원소 치유의학의 세계

Clin Interv Aging. 2006 Sep; 1(3): 261–265. 

Published online 2006 Sep. 

PMCID: PMC2695174

PMID: 18046879

Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging

Michael Janson

Author information Copyright and License information Disclaimer

This article has been cited by other articles in PMC.

Go to:

Abstract

Dietary supplements at high doses as part of medical therapy have been controversial, but the evidence suggests that they play a significant role in prevention and treatment of diseases as well as protection from accelerated aging that results from oxygen free-radical damage, inflammation, and glycation. This literature review examines several supplements that have documented roles in medical therapy, including vitamins C and E, coenzyme Q10, alpha-lipoic acid, chromium, L-carnitine, and quercetin. The evidence shows benefits in diabetes, cardiovascular disease, hypertension, congestive heart failure, age-related deterioration of brain function and vision, and immune function, as well as other age-related health problems.

- 비타민 C, E, 코엔자임큐텐, 알파리포산, 크롬, 카르니틴, 퀘르세틴이 당뇨, 심장질환, 고혈압, 노화로 인한 뇌기능저하, 시력저하, 면역력저하 등을 개선하는 효과가 있음. 

Keywords: orthomolecular, dietary supplements, anti-aging, vitamin C, vitamin E, coenzyme Q10

Go to:

Introduction

Dietary supplements, including vitamins, minerals, essential fatty acids, amino acids, flavonoids, herbs, and accessory food factors, are among the most valuable and safe substances for prevention and treatment of serious chronic and acute diseases associated with mortality, as well as everyday health problems that cause discomfort and disability. It is important to take adequate doses for their full benefits. Because they prevent deficiency diseases at low doses, they have acquired a reputation for being necessary only at these low levels. As a result, many physicians ignore the value of much higher doses that are useful for therapeutic purposes and protection from age-related degeneration.

Small amounts of essential nutrients treat deficiency diseases, but these conditions (scurvy, beri beri, pellagra, and rickets, for examples) are rarely seen in developed countries. Marginal nutrition associated with marginal health is much more likely to be the problem. For the most benefit from dietary supplements, it is important to ignore the RDA (recommended dietary allowances) levels that are found in food and most common dietary supplements and focus on the research that shows the benefits of appropriate doses, which are often much higher than the RDA.

Nutrients that are not essential but valuable as supplements include coenzyme Q10, alpha lipoic acid, GLA (gamma-linolenic acid), some non-essential amino acids, such as L-arginine, L-carnitine, and L-glutamine, and others. Additional valuable supplements, including flavonoids and other antioxidants, are found in foods but are not associated with specific deficiency diseases, although they provide specific health benefits in appropriate doses. People benefit from dietary supplements because of genetic physiological and biochemical variation, exposure to environmental contaminants, free radical damage from normal metabolism, exposure to ultraviolet light or ozone, and specific medical conditions. The process of aging leads to biochemical and physiological changes that can be slowed down and sometimes reversed through the appropriate use of dietary supplements.

Go to:

Orthomolecular medicine

Orthomolecular medicine is the restoration and maintenance of health through the administration of adequate amounts of substances that are normally present in the body. Nobel Prize winner Linus Pauling, one of the leading molecular chemists of the century, established this definition of orthomolecular medicine in 1968. The aging process is typically accelerated as a result of free radical exposure, frequent or chronic inflammation, and toxic exposures (such as to heavy metals or industrial and agricultural hydrocarbons). Reversing this process or slowing it down is one goal of orthomolecular therapy, along with treatment of health problems.

An increasing number of scientific studies have been confirm‎ing the view that high doses of nutrients are therapeutic and preventive. Vitamins C and E, beta-carotene, B-complex vitamins, and coenzyme Q10 are among the many nutrients that have been shown to contribute positively to health and longevity at doses much higher than the RDA(하루권장량). While therapeutic levels for minerals, such as magnesium, zinc, and chromium, are much closer to the RDA, supplements beyond what is normally present in foods may still be essential for prevention and treatment of disease and slowing the aging process.

Go to:

Supplements for anti-aging, prevention, and medical therapy

Vitamin C

Vitamin C has a wide range of metabolic functions. It offers protection from oxidative free-radical damage and it is essential for the production of collagen. Vitamin C reduces the wrinkling and sagging of the skin that occurs with aging. Vitamin C also helps maintain mucous membranes, adrenal hormone production, and immune function, including humoral immunity, and phagocytosis.

While the US RDA for vitamin C was recently raised (for men from 60 mg to its current 90 mg, and for women from 45 mg to 75 mg, and somewhat more for smokers), even higher doses have greater health benefits. For example, in a placebo controlled trial for six months, 40 men and women between 60 to 80 years old were administered 500 mg of vitamin C daily. This moderate dose of vitamin C modestly but significantly lowered blood pressure (Fotherby et al 2000). In another study of 514 people, plasma vitamin C levels were inversely related to blood pressure and pulse rate (Bates et al 1998). Elevated blood pressure is a risk factor for age-related atherosclerotic disease.

Early research showed a significant difference in leukocyte vitamin C during a viral infection depending on the level of supplementation (Figure ​(Figure1).1). At the start of an infection, vitamin C levels in leukocytes drops precipitously. With supplements of 200 mg, the initial level is higher, but it also drops quickly to about the same level as with no supplementation. With supplements of 6000 mg, the level starts much higher and stays above what is considered a normal baseline for the duration of the infection, and symptoms improve more quickly (Anderson 1979).

Figure 1

Leukocyte vitamin C during infections. High dose vitamin C (6 g daily before and during infection) enhances leukocyte ascorbate levels at baseline and during infections. Low dose supplements (200 mg daily) have less pronounced effects.

A 1979 study showed immune system benefit from daily administration of 1g of vitamin C. Two children with autosomal recessive genetic chronic granulomatous disease were given this dose, prior to which they had recurrent infections, abnormal neutrophil function, and elevated serum IgE levels. They became free of recurrent infections and gained weight with this dose. Their neutrophil motility and phagocytosis improved while their serum immunoglobulin E (IgE) levels dropped (Anderson and Dittrich 1979). Also in 1979, 10 patients with recurrent bacterial infections were noted to have abnormal neutrophil motility. Six of the patients were administered oral vitamin C (1 g daily for children and 3 g daily for adults). Testing at monthly intervals showed consistent improvement in neutrophil motility and clinical improvement in 5 of the 6 patients (Anderson and Theron 1979).

Another study in 1980 eval‎uated the effect of vitamin C at 1 g, 2 g, and 3 g doses showed that neutrophil motility was enhanced with the higher doses, but not when the lower dose of 1 g was administered (Anderson et al 1980). More recently, a Japanese study of vitamin C and upper respiratory infections showed that the frequency of colds could be reduced by a daily 500 mg supplement. In this research, 244 subjects completed a protocol in which they were assigned to a daily dose of either 50 mg or 500 mg of vitamin C. The frequency of colds was much less in the high-dose group. Those taking the 500 mg dose had a 66% lower relative risk of catching a common cold (Sasazuki et al 2006).

Age-related macular degeneration (AMD) is another disorder that is influenced by vitamin C and other nutrients. In the Age-Related Eye Disease Study (AREDS) subjects were administered a mixture of antioxidants and zinc, including 500 mg of vitamin C. In this multi-center trial, 3640 subjects at various stages of AMD were randomly assigned to the treatment group or placebo, and were followed for an average of 6.3 years. The supplements reduced the risk of developing advanced AMD by 28%, and the higher-risk subjects did even better (AREDS 2001).

Overall, research suggests that vitamin C provides a wide variety of benefits in daily doses from 500 mg to 6000 mg, and higher doses may be of value in some conditions. Many of these benefits would be of particular value to the elderly, with compromised immunity, degenerative heart and brain disorders, as well as cancer and inflammatory processes. I typically recommend 3000 mg to 6000 mg daily for many patients.

Vitamin E

Vitamin E refers to a family of substances including alpha-, beta-, gamma-, and delta-tocopherols. The primary one in most research is alpha-tocopherol, but some research suggests that gamma-tocopherol is also very important. These are all antioxidants, and have many anti-aging effects. Vitamin E protects low density lipoprotein-cholesterol (LDL-C) from oxidation, and numerous epidemiological studies have suggested that higher vitamin E intake is associated with reduced heart disease and cardiac deaths (Knekt et al 1994). Elderly people with higher vitamin E blood levels are less likely to have signs of vascular aging and have reduced levels of LDL oxidation (Cherubini et al 2001). More recent intervention studies have not shown the same benefits in patients who already have heart disease, possibly because many of the studies used only pure alpha-tocopherol, and most of them used synthetic vitamin E (dl-alpha-tocopherol), not the natural d-alpha-tocopherol, which is more active.

Vitamin E can also enhance immune function. Supplements of 200 IU to 800 IU are associated with reduced rates of infection in elderly subjects (Meydani, Han, et al 2004). A study of 451 elderly subjects showed that 200 IU of vitamin E could reduce the incidence of viral upper respiratory infections, which are commonly associated with numerous complications in this age group (Meydani, Leka, et al 2004).

Although some recent studies suggested that high doses of vitamin E might increase the risk of cardiovascular mortality, these studies were flawed in numerous ways, and their conclusions are unreliable. A subsequent review showed that both vitamin E and vitamin C are safe across a wide range of doses (at least up to 1600 IU for vitamin E, and 2000 mg for vitamin C). This review was authored by some of the most respected researchers in the field of vitamins and antioxidants (Hathcock et al 2005). They noted that a large number of people take a broad range of supplements well beyond the RDA, and that no consistent pattern of adverse effects has been seen at any dose for either vitamin. In addition, these supplements have important roles in antioxidant, free-radical protection, antiinflammatory effects, and other functions in maintaining homeostasis.

As noted above, vitamin E is one of the antioxidants that were studied in the AREDS research which showed benefits for AMD when administered in doses of 400 IU daily. The other nutrients in the AREDS research were zinc (80 mg), beta carotene (15 mg or 25 000 IU), and copper (2mg). Other antioxidants and carotenoids might also be useful for AMD, such as lutein (a carotenoid) and alpha-lipoic acid (a lipid and aqueous phase antioxidant).

Coenzyme Q10

Coenzyme Q10 (ubiquinone, or coQ10) is an antioxidant that is essential for mitochondrial energy production. It is manufactured in the body, but with aging the amounts are inadequate for optimum health. CoQ10 is essential for the heart muscle, and it helps lower blood pressure, improve congestive heart failure, and protect the brain in degenerative conditions such as Parkinson’s and Alzheimer’s diseases (Morisco et al 1993). Statin drugs significantly lower the production of coQ10. Typical supplemental doses of coQ10 range from 100 mg daily for prevention against high blood pressure to 400 mg for heart disease patients (Munkholm et al 1999). With severe congestive heart failure, higher doses may be beneficial. In neurologic disorders, research is now showing benefits from coQ10 in doses of 1200 mg or more (Schults et al 2002).

Alpha lipoic acid

Alpha lipoic acid (ALA) is a sulfur-containing antioxidant that acts in both aqueous and lipid fractions of cells and tissues. It helps to detoxify heavy metals, such as mercury, and it helps protect neurologic tissues, and at high enough doses it can reverse early stages of diabetic peripheral neuropathy. Typical doses are from 100–200 mg for general prevention and up to 1000 mg for diabetics with neuropathy (Hahm et al 2004). At the higher doses it also helps to control blood sugar (Jacob et al 1999). Animal studies show that ALA protects the heart mitochondria against aging effects.

Chromium

Chromium is a trace mineral that helps to regulate blood sugar and lipid levels. Typical nutritional levels range from 50 mcg to 200 mcg in well nourished people. However, in diabetic patients, high doses of chromium, which are extremely safe, can significantly reduce blood sugar and enhance insulin sensitivity (Anderson et al 1997). When 1000 mcg of chromium were administered to type II diabetics, 90% of them were able to eliminate the need for medication to control blood sugar levels (Anderson 1997). Chromium supplements also lower total cholesterol and increase high density lipoprotein levels.

L-carnitine

L-carnitine is essential for the transport of free fatty acids across the mitochondrial membrane, where they are metabolized to create energy. Low L-carnitine levels reduce the functional capacity of the myocardium, leading to increases in angina and congestive heart failure. Supplements reduce angina and reduce mortality in patients with myocardial infarction. I typically recommend supplements of 1000 mg to 2000 mg of L-carnitine for prevention of heart disease for heart patients, and more in acute conditions.

Quercetin

Quercetin is a flavonoid that helps to control allergy symptoms of rhinitis and sinusitis. It stabilizes the membranes of mast cells, reducing the release of histamine. It is also helpful in lowering the risk of cataract by inhibiting glycoprotein formation in the lens (Cornish, et al 2002). Typical doses of quercetin are 800 mg to 1200 mg daily.

Go to:

Conclusion

With basic knowledge of supplements, it is possible to avoid medications in the treatment and prevention of many health problems (Table ​(Table11 and ​and2).2). Numerous other supplements are valuable in appropriate doses, and they are part of a comprehensive health program, including diet, exercise, and stress management.

Table 1

Hypertension treatment program example

Supplement	Morning	Evening
High potency multivitamin	½ of daily dose	½ of daily dose
Vitamin C	1000–2000 mg	1000–2000 mg
Vitamin E	400 IU	(possibly another 400 IU)
Coenzyme Q10	100–200 mg
Magnesium	200–300 mg	200–300 mg
Garlic, deodorized	500–1000 mg	500–1000 mg
Fish oil	600–1200 mg	600–1200 mg
	omega-3	omega-3

Table 2

Management of elevated lipid levels with supplements

High potency multivitamin	½ of daily dose	½ of daily dose
Vitamin C	1000–2000 mg	1000–2000 mg
Policosanol	10 mg	10 mg
Chromium	200 mcg	200 mcg
L-Carnitine	500–1000 mg	500–1000 mg
Red yeast rice	500–1000 mg	500–1000 mg

Go to:

Footnotes

This article was previously published in Anti-Aging Medicine, the official journal of the Japanese Academy of Anti-Aging Medicine (JAAM), an international affiliate of the Society for Applied Research in Aging (SARA).

Go to:

References

• Anderson R, Dittrich OC. Effects of ascorbate on leucocytes: Part IV. Increased neutrophil function and clinical improvement after oral ascorbate in 2 patients with chronic granulomatous disease. S Afr Med J. 1979;56:476–80. [PubMed] [Google Scholar]
• Anderson R, Oosthuizen R, Maritz R, et al. The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers. Am J Clin Nutr. 1980;33:71–6. [PubMed] [Google Scholar]
• Anderson R, Theron A. Effects of ascorbate on leucocytes: Part III. In vitro and in vivo stimulation of abnormal neutrophil motility by ascorbate. S Afr Med J. 1979;56:429–33.[PubMed] [Google Scholar]
• Anderson R. Vitamin C and leukocyte ascorbate. Nutrition Today 1977 [Google Scholar]
• Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786–91.[PubMed] [Google Scholar]
• Anderson RA. Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr. 1997;16:404–10. [PubMed] [Google Scholar]
• [AREDS] Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417–36. [PMC free article] [PubMed] [Google Scholar]
• Bates CJ, Walmsley CM, Prentice A, et al. Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older. J Hypertens. 1998;16:925–32. [PubMed] [Google Scholar]
• Cherubini A, Zuliani G, Costantini F, et al. High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. J Am Geriatr Soc. 2001;49:651–4. [PubMed] [Google Scholar]
• Cornish KM, Williamson G, Sanderson J. Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. Free Radic Biol Med. 2002;33:63–70. [PubMed] [Google Scholar]
• Fotherby MD, Williams JC, Forster LA, et al. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens. 2000;18:411–15. [PubMed] [Google Scholar]
• Hahm JR, Kim BJ, Kim KW. Clinical experience with thioctacid (thioctic acid [lipoic acid]) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients. J Diabetes Complications. 2004;18:79–85. [PubMed] [Google Scholar]
• Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005;81:736–45. [PubMed] [Google Scholar]
• Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999;27:309–14. [PubMed] [Google Scholar]
• Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:1180–9. [PubMed] [Google Scholar]
• Meydani SN, Han SN, Hamer DH. Vitamin E and respiratory infection in the elderly. Ann N Y Acad Sci. 2004;1031:214–22. [PubMed] [Google Scholar]
• Meydani SN, Leka LS, Fine BC, et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA. 2004;292:828–36. [PMC free article][PubMed] [Google Scholar]
• Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig. 1993;71(8 Suppl):S134–6. [PubMed] [Google Scholar]
• Munkholm H, Hansen HH, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Biofactors. 1999;9:285–9. [PubMed] [Google Scholar]
• Sasazuki S, Sasaki S, Tsubono Y, et al. Effect of vitamin C on common cold: randomized controlled trial. Eur J Clin Nutr. 2006;60:9–17. [PubMed] [Google Scholar]
• Shults CW, Oakes D, Kieburtz K, et al. Parkinson Study Group Effects of coenzyme q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59:1541–50.[PubMed] [Google Scholar]